CIK 0001080014 · Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943265960
- Phone
- 6502389600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-15 | Zhen Marianne Chief Accounting Officer | Grant or award | +300 | 45,915 | ||
| 2024-08-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −975 | $18.49 | $18K | 45,615 |
| 2024-06-17 | Srivastava Sapna Director | Grant or award | +13,923 | 44,096 | ||
| 2024-06-17 | Srivastava Sapna Director | Grant or award · Non-statutory Stock Option | +10,000 | 22,500 | ||
| 2024-06-17 | Small Derek A Director | Grant or award | +13,923 | 23,172 | ||
| 2024-06-17 | Small Derek A Director | Grant or award · Non-statutory Stock Option | +10,000 | 10,833 | ||
| 2024-06-17 | Schlesinger Sarah J. Director | Grant or award | +13,923 | 118,629 | ||
| 2024-06-17 | Schlesinger Sarah J. Director | Grant or award · Non-statutory Stock Option | +10,000 | 30,000 | ||
| 2024-06-17 | Odysseas Kostas D Director | Grant or award | +13,923 | 122,625 | ||
| 2024-06-17 | Odysseas Kostas D Director | Grant or award · Non-statutory Stock Option | +10,000 | 30,000 | ||
| 2024-06-17 | Haimovitz Jules Director | Grant or award | +13,923 | 130,829 | ||
| 2024-06-17 | Haimovitz Jules Director | Grant or award · Non-statutory Stock Option | +10,000 | 30,000 | ||
| 2024-06-17 | DiPaolo Mark Director | Grant or award | +13,923 | 118,629 | ||
| 2024-06-17 | DiPaolo Mark Director | Grant or award · Non-statutory Stock Option | +10,000 | 30,000 | ||
| 2024-05-20 | Ronsheim Matthew See Remarks | Shares withheld for taxes | −268 | $16.13 | $4K | 40,510 |
| 2024-05-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −976 | $16.13 | $16K | 46,590 |
| 2024-03-05 | Basso Stephen Chief Financial Officer | Grant or award | +12,096 | $14.88 | $180K | 12,096 |
| 2024-03-05 | Basso Stephen Chief Financial Officer | Grant or award · Non-statutory Stock Option | +25,899 | 175,899 | ||
| 2024-03-05 | Ronsheim Matthew See Remarks | Grant or award | +12,768 | $14.88 | $190K | 40,778 |
| 2024-03-05 | Ronsheim Matthew See Remarks | Grant or award · Non-statutory Stock Option | +27,338 | 120,438 |
Page 4 of 10 · 181 trades